Clinical Trial Update: Optilene® Suture for Coronary Artery Bypass Graft Surgery

View source ↗

Summary

The clinical trial update indicates that the study evaluating the Optilene suture for coronary bypass graft surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Multi-vessel Coronary Artery Disease

Drugs mentioned

• Optilene Suture (polypropylene suture)

Snippet

Sponsor: Aesculap AG | Conditions: Coronary Heart Disease, Multi Vessel Coronary Artery Disease | Status: COMPLETED